GENETEC - What's its upcoming EPS (31-Mar-2022)?

CIMB

"we expect a lower qoq sales and net profit in 4QFY3/22F due to the shorter operating period." - From CIMB Research Report.

CLSA

From CIMB & CLSA estimation, the FY22 (31-Mar-22) eps is 8 cent.

GENETEC reported following EPS

• 30-Jun-21 - 16.28 cent
• 30-Sep-21 - 32.25 cent
• 31-Dec-21 - 35.83 cent
• 31-Mar-22 - ??

After the 12:1 bonus issue ex on 7-Jan-22, the reported EPS shall adjust to following numbers...

• 30-Jun-21 - 16.28 cent --> 1.25 cent
• 30-Sep-21 - 32.25 cent --> 2.48 cent
• 31-Dec-21 - 35.83 cent --> 2.76 cent
• 31-Mar-22  =  8 cent - 1.25 cent - 2.48 cent - 2.76 cent = 1.49 cent

I have extracted out the information from CLSA initiation report to list down what have and have not been priced in to their financial model & target price. Please visit and comment - https://klse1.i3investor.com/blogs/genetec_rm400/2022-04-15-story-h1621459606-GENETEC_CLSA_Target_Price_RM4_50_What_have_and_have_not_been_priced_in.jsp